1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY |
|||||||||||
|
UNI - EN REPORT No |
303 | / |
2026 |
|
||||||
Date of issue: |
2026-11-18 |
||||||||||
Short name of the issuer |
|||||||||||
SOPHARMA AD |
|||||||||||
Subject |
|||||||||||
Publication of materials for holding an Extraordinary General Meeting of Shareholders of “Sopharma” AD, scheduled for 15 January 2027 |
|||||||||||
Official market - legal basis |
|||||||||||
Art. 56 ust. 1 pkt 2 Ustawy o ofercie – informacje bieї№ce i okresowe |
|||||||||||
Unofficial market - legal basis |
|||||||||||
Contents of the report: |
|||||||||||
Sofia, Bulgaria, November 18, 2026 - According to the requirements of Art. 100t of the Law on Public Offering of Securities the Board of directors of “Sopharma” AD (SFA: “BSE“ AD, SPH: Warsaw Stock Exchange) presents the following materials on the agenda of EGM convened for January 15, 2027 and in the absence of a quorum on this date – for February 05, 2027, to the attention of shareholders, which will be available on the website of Extri News (www.x3news.com), in the FSC system, on the Company's website www.sopharmagroup.com and on the website www.investor.bg, as well as in hard copy at the address of the Company: |
|||||||||||
Annexes |
|||||||||||
File |
Description |
||||||||||
Publication of materials for holding an Extraordinary General Meeting of Shareholders of “Sopharma” AD, scheduled for 15 January 2027 |
|||||||||||
Legal framework |
Type of information |
||||
TRANSD |
Inside information |
||||
RegulatoryData |
|||||
Collection Body |
PLKNF |
||||
Unique data record identifier |
|||||
Type of submission |
New (to be used for new information) |
||||
Voluntary information flag |
|||||
Date or period covered [Date or beginning of the period to which the information relates] |
2027-01-15 |
||||
Date or period covered [Date or end of the period to which the information relates] |
2027-01-15 |
||||
Personal data flag |
|||||
Macierzyste państwo członkowskie, w stosownych przypadkach |
PL |
||||
DocumentReference |
|||||
Język, w którym przekazano informacje |
Oryginał (ORIG) czy tłumaczenie (TRAN) |
Numer referencyjny pliku danych |
|||
PL |
ORIG |
||||
SubmittingEntity |
|||||
Submitting entity LEI |
or |
Submitting entity name - natural person |
|||
RelatedEntity/LegalPerson |
|||||
Entity LEI |
Size of the entity |
Industry sector(s) |
|||
097900BGGW0000048796 |
Large undertaking |
(acc. NACE): C |
|||
SOPHARMA AD |
|||||||||||||
(fullname of the issuer) |
|||||||||||||
SOPHARMA AD |
Farmaceutyczny (far) |
||||||||||||
(short name of the issuer) |
(sector according to clasification of the WSE in Warsow) |
||||||||||||
1220 |
Sofia |
||||||||||||
(post code) |
(city) |
||||||||||||
IlienskoShosse |
16 | ||||||||||||
(street) |
(number) |
||||||||||||
+359 2 813 42 00 |
+359 2 936 02 86 |
||||||||||||
(phone number) |
(fax) |
||||||||||||
(e-mail) |
(web site) |
||||||||||||
nd |
|||||||||||||
(NIP) |
(REGON) |
||||||||||||
SIGNATURE OF PERSONS REPRESENTING THE COMPANY |
|||||
Date |
Name |
Position / Function |
Signature |
||
2026-11-18 |
Ognian Ivanov Donev |
Executive Director |
|||


































































